Brief: Crossject reports positive results with needle free ZENEO Methrotrexate

Crossject SA

24/11/2014 07:30

Nov 24 (Reuters) - Crossject SA  ALCJ.PA : 
    * Reports positive results from bioequivalence study with 
needle free ZENEO Methrotrexate 
    * Announces similarity between ZENEO Methotrexate 
needle-free injection system and current injectable formulation 
    * ZENEO Methotrexate meets its objectives in key 
bioequivalence study 
 
Source text for Eikon:  ID:nPre6mq1va  
Further company coverage:  ALCJ.PA  
 
 (Gdynia Newsroom: +48 58 698 39 20; 
Gdynia.newsroom@thomsonreuters.com) 
 
Keywords: CROSSJECT/BRIEF